You have full text access to this OnlineOpen article

Prolongation of P300 latency is associated with the duration of illness in male schizophrenia patients

  1. YUKIKO MORI md ,
  2. SADATOSHI KUROSU bm ,
  3. YUJI HIROYAMA md ,
  4. SHIN-ICHI NIWA md

Article first published online: 14 SEP 2007

DOI: 10.1111/j.1440-1819.2007.01695.x

Issue

Psychiatry and Clinical Neurosciences

Psychiatry and Clinical Neurosciences

Volume 61, Issue 5, pages 471–478, October 2007

Additional Information

How to Cite

MORI, Y., KUROSU, S., HIROYAMA, Y. and NIWA, S.-I. (2007), Prolongation of P300 latency is associated with the duration of illness in male schizophrenia patients. Psychiatry and Clinical Neurosciences, 61: 471–478. doi: 10.1111/j.1440-1819.2007.01695.x

Author Information

  1. Department of Neuropsychiatry, Fukushima Medical University School of Medicine, Fukushima, Japan

*Yukiko Mori, MD, Asaka Hospital, 45 Keitan, Sasagawa, Asakamachi, Koriyama, Fukushima 963-0198, Japan. Email: glacier@fmu.ac.jp

Publication History

  1. Issue published online: 14 SEP 2007
  2. Article first published online: 14 SEP 2007
  3. Received 1 May 2006; revised 27 April 2007; accepted 11 May 2007.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (100K)

REFERENCES

  • 1
    Saijo T, Abe T, Someya Y et al. Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study. Psychiatry Clin. Neurosci. 2001; 55: 41–7.
    Direct Link:
  • 2
    Rapoport JL, Giedd JN, Blumenthal J et al. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 1999; 56: 649–54.
  • 3
    Davis KL, Buchsbaum MS, Shihabuddin L et al. Ventricular enlargement in poor-outcome schizophrenia. Biol. Psychiatry 1998; 43: 783–93.
  • 4
    DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997; 74: 129–40.
  • 5
    Nair TR, Christensen JD, Kingsbury SJ, Kumar NG, Terry WM, Garver DL. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res. 1997; 74: 141–50.
  • 6
    Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HG Jr, McSparren J. Progressive ventricular enlargement in schizophrenia: Comparison to bipolar affective disorder and correlation with clinical course. Biol. Psychiatry 1990; 27: 341–52.
  • 7
    Kemali D, Maj M, Galderisi S, Milici N, Salvati A. Ventricle-to-brain ratio in schizophrenia: A controlled follow-up study. Biol. Psychiatry 1989; 26: 756–9.
  • 8
    Rapoport JL, Giedd J, Kumra S et al. Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch. Gen. Psychiatry 1997; 54: 897–903.
  • 9
    DeLisi LE, Tew W, Xie S et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings. Biol. Psychiatry 1995; 38: 349–60.
  • 10
    Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 2001; 58: 148–57.
  • 11
    Gur RE, Cowell P, Turetsky BI et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry 1998; 55: 145–52.
  • 12
    Jacobsen LK, Giedd JN, Castellanos FX et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am. J. Psychiatry 1998; 155: 678–85.
  • 13
    Maynard TM, Sikich L, Lieberman JA, LaMantia AS. Neural development, cell-cell signaling, and the ‘two-hit’ hypothesis of schizophrenia. Schizophr. Bull. 2001; 27: 457–76.
  • 14
    McCarley RW, Wible CG, Frumin M et al. MRI anatomy of schizophrenia. Biol. Psychiatry 1999; 45: 1099–119.
  • 15
    Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry 1998; 155: 1661–70.
  • 16
    Ford JM, Pfefferbaum A, Roth W. P3 and schizophrenia. Ann. N.Y. Acad. Sci. 1992; 658: 146–62.
    Direct Link:
  • 17
    McCarley RW, Faux SF, Shenton ME, Nestor PG, Adams J. Event-related potentials in schizophrenia: Their biological and clinical correlates and a new model of schizophrenic pathophysiology. Schizophr. Res. 1991; 4: 209–31.
  • 18
    Pritchard WS. Cognitive event-related potential correlates of schizophrenia. Psychol. Bull. 1986; 100: 43–66.
  • 19
    Blackwood DH, St Clair DM, Muir WJ, Duffy JC. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch. Gen. Psychiatry 1991; 48: 899–909.
  • 20
    Pfefferbaum A, Wenegrat BG, Ford JM, Roth WT, Kopell BS. Clinical application of the P3 component of event-related potentials. II. Dementia, depression and schizophrenia. Electroencephalogr. Clin. Neurophysiol. 1984; 59: 104–24.
  • 21
    Weir N, Fiaschi K, Machin D. The distribution and latency of the auditory P300 in schizophrenia and depression. Schizophr. Res. 1998; 31: 151–8.
  • 22
    Goodin DS. Clinical utility of long latency ‘cognitive’ event-related potentials (P3): The pros. Electroencephalogr. Clin. Neurophysiol. 1990; 76: 2–5.
  • 23
    Pfefferbaum A, Ford JM, Kraemer HC. Clinical utility of long latency ‘cognitive’ event-related potentials (P3): The cons. Electroencephalogr. Clin. Neurophysiol. 1990; 76: 6–12.
  • 24
    Polich J. Meta-analysis of P300 normative aging studies. Psychophysiology 1996; 33: 334–53.
    Direct Link:
  • 25
    Mathalon DH, Ford JM, Rosenbloom M, Pfefferbaum A. P300 reduction and prolongation with illness duration in schizophrenia. Biol. Psychiatry 2000; 47: 413–27.
  • 26
    O'Donnell BF, Faux SF, McCarley RW et al. Increased rate of P300 latency prolongation with age in schizophrenia. Electrophysiological evidence for a neurodegenerative process. Arch. Gen. Psychiatry 1995; 52: 544–9.
  • 27
    Frangou S, Sharma T, Alarcon G et al. The Maudsley Family Study, II. Endogenous event-related potentials in familial schizophrenia. Schizophr. Res. 1997; 23: 45–53.
  • 28
    Olichney JM, Iragui VJ, Kutas M, Nowacki R, Morris S, Jeste DV. Relationship between auditory P300 amplitude and age of onset of schizophrenia in older patients. Psychiatry Res. 1998; 79: 241–54.
  • 29
    Garver DL. The etiologic heterogeneity of schizophrenia. Harv. Rev. Psychiatry 1997; 4: 317–27.
  • 30
    McCarley RW, Hsiao JK, Freedman R, Pfefferbaum A, Donchin E. Neuroimaging and the cognitive neuroscience of schizophrenia. Schizophr. Bull. 1996; 22: 703–25.
  • 31
    McGlashan TH. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr. Bull. 1998; 14: 515–42.
  • 32
    Bardenstein KK, McGlashan TH. Gender differences in affective, schizoaffective, and schizophrenic disorders. A review. Schizophr. Res. 1990; 3: 159–72.
  • 33
    Nopoulos P, Flaum M, Andreasen NC. Gender differences in brain morphology in schizophrenia. Am. J. Psychiatry 1997; 154: 1648–54.
  • 34
    Andreasen NC, Ehrhardt JC, Swayze VW II et al. Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch. Gen. Psychiatry 1990; 47: 35–44.
  • 35
    Bryant NL, Buchanan RW, Vladar K, Breier A, Rothman M. Gender differences in temporal lobe structures of patients with schizophrenia: A volumetric MRI study. Am. J. Psychiatry 1999; 156: 603–9.
  • 36
    Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 1990; 35: 1–13.
  • 37
    McDonald B, Highley JR, Walker MA et al. Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. Am. J. Psychiatry 2000; 157: 40–47.
  • 38
    Goldstein JM, Seidman LJ, Goodman JM et al. Are there gender differences in neuropsychological functions among patients with schizophrenia? Am. J. Psychiatry 1999; 155: 1358–64.
  • 39
    Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr. Bull. 1990; 16: 185–94.
  • 40
    Häfner H, Behrens S, De Vry J, Gattaz WF. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur. Arch. Psychiatry Clin. Neurosci. 1991; 241: 65–8.
View Full Article (HTML) Get PDF (100K)